# Invesco Europe Enhanced Equity UCITS ETF (IQEX) **Page:** https://fundology.uk/fund/iqex · ISIN IE000YNVI4W4 ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 13/11/2026, IQEX (Invesco Europe Enhanced Equity UCITS ETF, ISIN IE000YNVI4W4) closed at £5.27 on the London Stock Exchange. Its ongoing charge is 0.24% a year (about £24 on £10,000). Over the year to 13/11/2026 its total return was +10.9%, or +7.0% after UK CPIH inflation. ## Summary Invesco Markets II PLC - Invesco Europe Enhanced Equity UCITS ETF is an exchange-traded fund (ETF) from Invesco, launched in 2025. It tracks the No Underlying Index. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.24% a year — about £24 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. Latest close: **£5.27** (13/11/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | IQEX | | ISIN | IE000YNVI4W4 | | Also listed as | IQEA (London Stock Exchange, US dollars), IQHE (Xetra, euros) | | Category | European shares | | Type | ETF | | Provider | Invesco | | Income | Accumulating | | Ongoing charge | 0.24% a year (£24 per £10,000) | | Fund size | £402m | | Launched | 2025 | | Domicile | Ireland | | UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 17/09/2025 | ## Past returns (periods to 13/11/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | +10.89% | +6.96% | income reinvested | Returns: as reported (delayed data). Inflation: UK CPIH, latest month published. ## Calendar-year returns Calendar-year returns of Invesco Markets II PLC - Invesco Europe Enhanced Equity UCITS ETF in pounds (price, with income reinvested in the fund): 2026 to 13/11/2026 +10.3%. Returns of Invesco Markets II PLC - Invesco Europe Enhanced Equity UCITS ETF in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +15.0%. | Year | Return | After CPIH inflation | Measured as | |---|---|---|---| | 2026 to 13/11/2026 | +10.3% | +6.8% | Price | ## Risk metrics | Window | Volatility | Max drawdown | |---|---|---| | 1 year | 13.27% | -10.27% | ## Largest fall Volatility of Invesco Markets II PLC - Invesco Europe Enhanced Equity UCITS ETF in pounds, annualised from weekly returns to 13/11/2026: 13.3% over 1 year. Largest fall in the price of Invesco Markets II PLC - Invesco Europe Enhanced Equity UCITS ETF since September 2025, in pounds: −10.3% from 27/02/2026 to 20/03/2026. On 13/11/2026 the price of Invesco Markets II PLC - Invesco Europe Enhanced Equity UCITS ETF was 1.9% below its highest weekly close since September 2025 (07/08/2026), in pounds. ## Charges compared with similar funds Ongoing charge of Invesco Markets II PLC - Invesco Europe Enhanced Equity UCITS ETF 0.24% a year. Compared on 14/11/2026, 113 of the 242 other European share funds charge more, 1 the same and 128 less (share classes counted once). ## Charges & eligibility - Ongoing charges figure (OCF): **0.24%** per year (as of 13/11/2026) - Stocks and shares ISA eligible: usually (check with your platform) - SIPP eligible: usually (check with your provider) - ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify. ## What it holds As of 12/11/2026, IQEX holds 241 positions, according to its published holdings. The largest is ASML at 4.26% of the fund; the ten largest make up 23.0%. ### Top holdings Largest positions (as of 12/11/2026), as a percentage of the whole fund: | # | Holding | Ticker | Weight | |---|---|---|---| | 1 | ASML | [ASML](https://fundology.uk/stock/ASML) | 4.26% | | 2 | Roche | [RO](https://fundology.uk/stock/RO) | 2.76% | | 3 | Novartis | [NOVN](https://fundology.uk/stock/NOVN) | 2.61% | | 4 | HSBC | [HSBA](https://fundology.uk/stock/HSBA) | 2.42% | | 5 | Shell | [SHEL](https://fundology.uk/stock/SHEL) | 2.33% | | 6 | AstraZeneca | [AZN](https://fundology.uk/stock/AZN) | 1.92% | | 7 | Nestle | [NESN](https://fundology.uk/stock/NESN) | 1.89% | | 8 | AXA | [CS](https://fundology.uk/stock/CS) | 1.63% | | 9 | Siemens | [SIE](https://fundology.uk/stock/SIE) | 1.63% | | 10 | SAP | [SAP](https://fundology.uk/stock/SAP) | 1.58% | ## Where it invests Shares of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed. ### By sector As published for the fund, as of 05/11/2026. | Sector | Weight | |---|---| | Financials | 25.2% | | Industrials | 18.4% | | Health Care | 12.7% | | Consumer Staples | 8.5% | | Information Technology | 8.3% | | Energy | 6.8% | | Consumer Discretionary | 5.8% | | Materials | 5.0% | | Other sectors | 9.2% | ### By country As published for the fund, as of 05/11/2026. | Country | Weight | |---|---| | United Kingdom | 15.9% | | United States | 14.0% | | Germany | 13.7% | | France | 12.6% | | Netherlands | 8.8% | | Switzerland | 8.1% | | Spain | 6.5% | | Italy | 4.1% | | Other countries | 16.3% | All 241 holdings: https://fundology.uk/fund/iqex/holdings ## Questions people ask **What is the ongoing charge of IQEX?** The ongoing charge of IQEX is 0.24% a year — about £24 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Invesco Markets II PLC - Invesco Europe Enhanced Equity UCITS ETF 0.24% a year. Compared on 14/11/2026, 113 of the 242 other European share funds charge more, 1 the same and 128 less (share classes counted once). **Is IQEX accumulating or distributing?** IQEX is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. **What is the ISIN of IQEX?** The ISIN of IQEX is IE000YNVI4W4. An ISIN identifies one exact share class of a fund; IQEX is its ticker on the London Stock Exchange. The same share class is also listed as IQEA (London Stock Exchange, US dollars) and IQHE (Xetra, euros). **What does IQEX hold?** As of 12/11/2026, IQEX holds 241 positions, according to its published holdings. The largest is ASML at 4.26% of the fund; the ten largest make up 23.0%. Its ten largest holdings are ASML (4.26%), Roche (2.76%), Novartis (2.61%), HSBC (2.42%), Shell (2.33%), AstraZeneca (1.92%), Nestle (1.89%), AXA (1.63%), Siemens (1.63%) and SAP (1.58%). **What were IQEX’s returns in each of the last five years?** Calendar-year returns of IQEX in pounds (price, with income reinvested in the fund): 2026 to 13/11/2026 +10.3%. Past performance is not a guide to future returns. **How has IQEX done after inflation?** Over the year to 13/11/2026 IQEX’s total return was +10.9%, or +7.0% after UK CPIH inflation. Past performance is not a guide to future returns. --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.